or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO F -0.14 3.06
    NVS F -1.01 1.74

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Biopharmaceutical Biotechnology Blood Test Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs Endocrine System Eye Eye Care Eye Care Products Eyewear
    Industries: Biotechnology Drug Manufacturers - Major

    Recent News for iShares MSCI International Developed Quality Factors ETF & its Holdings

    Date Stock Title
    Nov 13 NVS Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
    Nov 13 NVO Amgen Rebounds, Shaking Off 'Overdone' Fears Tied To Its Weight-Loss Shot
    Nov 13 NVO Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
    Nov 13 NVS Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)
    Nov 13 NVS 5 Low-Leverage Stocks to Buy Amid the Focus on Inflation Data
    Nov 13 NVS Q3 2024 Voyager Therapeutics Inc Earnings Call
    Nov 13 NVS Schrodinger announces expanded license agreement with Novartis
    Nov 13 NVS Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
    Nov 13 NVS Q3 2024 Legend Biotech Corp Earnings Call
    Nov 13 NVS Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
    Nov 13 NVS Q3 2024 Schrodinger Inc Earnings Call
    Nov 12 NVO Novo Nordisk A/S (NVO): A Bull Case Theory
    Nov 12 NVO Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot
    Nov 12 NVS Top Stock Reports for Netflix, Salesforce & Cisco
    Nov 12 NVS Schrödinger gains on Novartis deal despite Q3 miss
    Nov 12 NVS Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
    Nov 12 NVO Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
    Nov 11 NVO Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
    Nov 11 NVO Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
    Nov 11 NVO Novo Nordisk: Be Greedy When Others Are Fearful
    The investment seeks to track the investment results of the MSCI World ex USA Sector Neutral Quality Index. The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The index measures the performance of international developed large- and mid-capitalization stocks exhibiting relatively higher quality characteristics as identified through three fundamental variables: return on equity, earnings variability and debt-to-equity. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund MSCI EAFE Msci World
    Back to the Main IQLT Page...